By integrating clinicopathological variables with independent prognostic significance and the PRL scoring model, we developed a nomogram to predict the 1-year, 3-year, and 5-year survival probabilities of HCC patients in two independent cohorts. This evidence concerns the gene PRL and hepatocellular carcinoma.